NDC 42571-381

CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE

Chlordiazepoxide Hcl And Clidinium Bromide

CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Micro Labs Limited. The primary component is Chlordiazepoxide Hydrochloride; Clidinium Bromide.

Product ID42571-381_e4508328-6e1f-4234-e053-2995a90a4a40
NDC42571-381
Product TypeHuman Prescription Drug
Proprietary NameCHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE
Generic NameChlordiazepoxide Hcl And Clidinium Bromide
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2022-10-01
Marketing CategoryANDA /
Application NumberANDA215835
Labeler NameMicro Labs Limited
Substance NameCHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE
Active Ingredient Strength5 mg/1; mg/1
Pharm ClassesAnticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]
DEA ScheduleCIV
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 42571-381-01

100 CAPSULE in 1 BOTTLE (42571-381-01)
Marketing Start Date2022-10-01
NDC Exclude FlagN
Sample Package?N

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.